← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Billings Clinic Foundation
Billings, MT
$5,021,037
Total funding
4
Grants
Funding over time
peak $869.7K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,865,666 · 2
AHRQ$1,155,371 · 2
By mechanism
R18$3,344,766 · 2
R01$1,676,271 · 1
R03$0 · 1
Investigators at Billings Clinic Foundation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT$566,039
R18 · FY2006 · DK
USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT$545,697
R18 · FY2005 · DK
USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT$545,193
R18 · FY2004 · DK
USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT$532,466
R18 · FY2007 · DK
The Effectiveness of an HIT-based Care Transition Information Transfer System to$448,930
R18 · FY2008 · HS
The Effectiveness of an HIT-based Care Transition Information Transfer System to$399,408
R18 · FY2009 · HS
Circulating Tumor Cells in Non-Small Cell Lung Cancer$337,278
R01 · FY2010 · CA
Circulating Tumor Cells in Non-Small Cell Lung Cancer$337,278
R01 · FY2008 · CA
Circulating Tumor Cells in Non-Small Cell Lung Cancer$337,278
R01 · FY2009 · CA
Circulating Tumor Cells in Non-Small Cell Lung Cancer$337,278
R01 · FY2007 · CA
Circulating Tumor Cells in Non-Small Cell Lung Cancer$327,159
R01 · FY2011 · CA
The Effectiveness of an HIT-based Care Transition Information Transfer System to$307,033
R18 · FY2010 · HS
Coordinated Office Approach to Diabetes Management$0
R03 · FY2005 · HS